Abstract
Purpose of Review
Many patients with decompensated cirrhosis will be re-admitted within 30 days after discharge. Why many of these readmissions reflect the severity of the patients underlying disease—and can be lifesaving—others may be preventable, revealing gaps in systems of care. This review summarizes reasons for and interventions designed to improve readmission rates and why they work (or do not).
Recent Findings
The principle reasons for readmission include hepatic encephalopathy, symptomatic ascites, complications of medical management, and substance abuse-related admissions. Strategies to reduce readmissions generally succeed in two ways: (1) developing and providing viable alternatives to hospitalization for early decompensations and (2) optimal utilization of proven therapeutic modalities for the treatment of hepatic encephalopathy. Interventions can be targeted (aiming to improve one component of care), structural (reorganizing care delivery to improve quality), and comprehensive (structural with multiple targeted approaches). Recent literature has shown how smartphone applications may be developed to help reduce readmissions.
Summary
Interventions that aim to reduce readmissions among patients with decompensated cirrhosis should be developed with reference to the lessons from prior published reports.
Similar content being viewed by others
References
Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance
•• Tapper EB. Building effective quality improvement programs in liver disease: a systematic review of quality improvement initiatives. Clinical Gastroenterology and Hepatology. 2016. In this systematic review of quality improvement interventions for patients with cirrhosis, programs that aimed to reduce 30-day readmissions are catalogued along with those that aimed to improve therapy for bleeding, spontaneous bacterial peritonitis, vaccination rates, and liver cancer screening.
Bajaj JS, O’Leary JG, Reddy KR, Wong F, Olson JC, Subramanian RM, et al. Second infections independently increase mortality in hospitalized patients with cirrhosis: the north american consortium for the study of end-stage liver disease (NACSELD) experience. Hepatology. 2012;56(6):2328–35. https://doi.org/10.1002/hep.25947.
Tapper EB, Risech-Neyman Y, Sengupta N. Psychoactive medications increase the risk of falls and fall-related injuries in hospitalized patients with cirrhosis. Clin Gastroenterol Hepatol. 2015;13(9):1670–5. https://doi.org/10.1016/j.cgh.2015.03.019.
Kortebein P, Ferrando A, Lombeida J, Wolfe R, Evans WJ. Effect of 10 days of bed rest on skeletal muscle in healthy older adults. JAMA. 2007;297(16):1769–74. https://doi.org/10.1001/jama.297.16.1772-b.
Tapper EB. Challenge accepted: confronting readmissions for our patients with cirrhosis. Hepatology. 2016;64(1):26–8. https://doi.org/10.1002/hep.28471.
Singal AG, Rahimi RS, Clark C, Ma Y, Cuthbert JA, Rockey DC, et al. An automated model using electronic medical record data identifies patients with cirrhosis at high risk for readmission. Clin Gastroenterol Hepatol. 2013;11(10):1335–41. e1. https://doi.org/10.1016/j.cgh.2013.03.022.
Tapper EB, Finkelstein D, Mittleman MA, Piatkowski G, Lai M. Standard assessments of frailty are validated predictors of mortality in hospitalized patients with cirrhosis. Hepatology. 2015.
• Tapper EB, Halbert B, Mellinger J. Rates of and reasons for hospital readmissions in patients with cirrhosis: a multistate population-based cohort study. Clinical Gastroenterology and Hepatology. 2016. This study compiles all admissions for patients with cirrhosis in six states and indicates that hepatic encephalopathy is a major driver of 30- and 90-day readmission risk.
• Bajaj JS, Reddy KR, Tandon P, Wong F, Kamath PS, Garcia-Tsao G, et al. The 3-month readmission rate remains unacceptably high in a large North American cohort of patients with cirrhosis. Hepatology. 2016;64(1):200–8. The first multicenter study of readmission risk for patients with acutely decompensated cirrhosis. Focuses on 90-day readmission for patients with infections and highlights the effect of hepatic encephalopathy and proton pump inhibitors. https://doi.org/10.1002/hep.28414.
Li R, Tierney A, Carr R. The impact of peri-discharge interventions on 30-day readmission and 90-day mortality rates for patients admitted with hepatic encephalopathy. Am J Gastroenterol. 2014;109:S131–S.
Morando F, Maresio G, Piano S, Fasolato S, Cavallin M, Romano A, et al. How to improve care in outpatients with cirrhosis and ascites: a new model of care coordination by consultant hepatologists. J Hepatol. 2013;59(2):257–64. https://doi.org/10.1016/j.jhep.2013.03.010.
Tapper EB, Finkelstein D, Mittleman MA, Piatkowski G, Chang M, Lai M. A quality improvement initiative reduces 30-day rate of readmission for patients with cirrhosis. Clinical gastroenterology and hepatology: the official clinical practice journal of the American Gastroenterological Association. 2015.
Wigg AJ, McCormick R, Wundke R, Woodman RJ. Efficacy of a chronic disease management model for patients with chronic liver failure. Clin Gastroenterol Hepatol. 2013;11(7):850–8. e4. https://doi.org/10.1016/j.cgh.2013.01.014.
•• Russo MW, Levi DM, Pierce R, Casingal V, Eskind L, de Lemos A, et al. A prospective study of a protocol that reduces readmission after liver transplantation. Liver Transplantation. 2016. Though this study focuses exclusively on post-transplant readmissions, it is the clearest available case of exemplary quality improvement efforts to define, track, and modify readmission risks in patients with complex liver disease.
Volk ML, Tocco RS, Bazick J, Rakoski MO, Lok AS. Hospital readmissions among patients with decompensated cirrhosis. Am J Gastroenterol. 2012;107(2):247–52. https://doi.org/10.1038/ajg.2011.314.
•• Kanwal F, Asch SM, Kramer JR, Cao Y, Asrani S, El-Serag HB. Early outpatient follow-up and 30-day outcomes in patients hospitalized with cirrhosis. Hepatology. 2016. This study evaluates the impact of early clinical follow-up after discharge and demonstrates an association with readmission and inverse association with mortality. The clear message from this paper is that efforts that capture early decompensations after discharge will save lives but increase readmissions, partcularly if alternatives to re-hospitalization are not available.
Tapper EB, Finkelstein D, Mittleman MA, Piatkowski G, Lai M. Standard assessments of frailty are validated predictors of mortality in hospitalized patients with cirrhosis. Hepatology. 2015;62(2):584–90. https://doi.org/10.1002/hep.27830.
Volk ML, Kanwal F. Quality of care in the cirrhotic patient. Clinical and translational gastroenterology. 2016;7(4):e166. https://doi.org/10.1038/ctg.2016.25.
Tapper EB. Early readmissions after liver transplantation and the power of quality improvement. Liver Transpl. 2016;22(6):717–9. https://doi.org/10.1002/lt.24430.
Feltner C, Jones CD, Cené CW, Zheng Z-J, Sueta CA, Coker-Schwimmer EJ, et al. Transitional care interventions to prevent readmissions for persons with heart failure. A systematic review and meta-analysis transitional care for persons with heart failure. Ann Intern Med. 2014;160(11):774–84. https://doi.org/10.7326/M14-0083.
Bradley EH, Curry L, Horwitz LI, Sipsma H, Wang Y, Walsh MN, et al. Hospital strategies associated with 30-day readmission rates for patients with heart failure. Circulation: Cardiovasc Qual Outcomes. 2013;6(4):444–50. https://doi.org/10.1161/CIRCOUTCOMES.111.000101.
Cohn KH, Schwartz RW. Business plan writing for physicians. Am J Surg. 2002;184(2):114–20. https://doi.org/10.1016/S0002-9610(02)00921-2.
Johnson E, Spier B, Leff J, Lucey M, Said A. Optimising the care of patients with cirrhosis and gastrointestinal haemorrhage: a quality improvement study. Aliment Pharmacol Ther. 2011;34(1):76–82. https://doi.org/10.1111/j.1365-2036.2011.04692.x.
Wundke R, Altus R, Sandford J, Wigg A. Improving management of oesophageal varices in patients with cirrhosis. Quality and Safety in Health Care. 2010;19(6):536–41. https://doi.org/10.1136/qshc.2009.036525.
Burke RE, Coleman EA. Interventions to decrease hospital readmissions: keys for cost-effectiveness. JAMA Intern Med. 2013;173(8):695–8. https://doi.org/10.1001/jamainternmed.2013.171.
Hansen LO, Young RS, Hinami K, Leung A, Williams MV. Interventions to reduce 30-day rehospitalization: a systematic review. Ann Intern Med. 2011;155(8):520–8. https://doi.org/10.7326/0003-4819-155-8-201110180-00008.
• Tapper EB, Finkelstein D, Mittleman MA, Piatkowski G, Chang M, Lai M. A quality improvement initiative reduces 30-day rate of readmission for patients with cirrhosis. Clin Gastroenterol Hepatol. 2016;14(5):753–9. A quality improvement intervention based on default orders in the electronic ordering system reduced 30-day readmissions primarily by improving care for overt hepatic encephalopathy. Notably, a checklist intervention was ineffective. https://doi.org/10.1016/j.cgh.2015.08.041.
Bass NM, Mullen KD, Sanyal A, Poordad F, Neff G, Leevy CB, et al. Rifaximin treatment in hepatic encephalopathy. N Engl J Med. 2010;362(12):1071–81. https://doi.org/10.1056/NEJMoa0907893.
Desai AP, Satoskar R, Appannagari A, Reddy KG, Te HS, Reau N, et al. Co-management between hospitalist and hepatologist improves the quality of care of inpatients with chronic liver disease. J Clin Gastroenterol. 2014;48(4):e30–e6. https://doi.org/10.1097/MCG.0b013e3182a87f70.
• Ghaoui R, Friderici J, Desilets DJ, Lagu T, Visintainer P, Belo A, et al. Outcomes associated with a mandatory gastroenterology consultation to improve the quality of care of patients hospitalized with decompensated cirrhosis. J Hosp Med. 2015;10(4):236–41. Mandatory consultation by gastroenterologists did not reduce readmissions but was associated with improved quality of care. https://doi.org/10.1002/jhm.2314.
Tapper EB, Friderici J, Borman ZA, Alexander J, Bonder A, Nuruzzaman N, et al. A multicenter evaluation of adherence to 4 major elements of the Baveno guidelines and outcomes for patients with acute variceal hemorrhage. J Clin Gastroenterol. 2017:1. https://doi.org/10.1097/MCG.0000000000000820.
Kanwal F, Asch SM, Kramer JR, Cao Y, Asrani S, El-Serag HB. Early outpatient follow-up and 30-day outcomes in patients hospitalized with cirrhosis. Hepatology. 2016;64(2):569–81. https://doi.org/10.1002/hep.28558.
•• Ganapathy D, Acharya C, Lachar J, Patidar K, Sterling RK, et al. The patient buddy app can potentially prevent hepatic encephalopathy-related readmissions. Liver International. 2017. An app that tracked patient reported outcomes including daily weights, timed-up-and-go tests, and scores on the EncephalApp Stroop program for assessing cognitivie function was feasible with promising though negative results.
Halpern SD, Ubel PA, Asch DA. Harnessing the power of default options to improve health care. N Engl J Med. 2007;357(13):1340–4. https://doi.org/10.1056/NEJMsb071595.
Tapper EB, Volk M. Strategies to reduce 30-day readmissions in patients with cirrhosis. Current gastroenterology reports. 2017;19(1):1. https://doi.org/10.1007/s11894-017-0543-3.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflicts of Interest
Elliot B. Tapper reports grants from Valeant, grants from Gilead, personal fees from Novartis, and personal fees from Dova, outside the submitted work.
Human and Animal Rights and Informed Consent
This article does not contain any studies with human or animal subjects performed by the author.
Additional information
This article is part of the Topical Collection on Management of Cirrhotic Patient
Rights and permissions
About this article
Cite this article
Tapper, E.B. Tackling 30-Day Readmissions in Patients with Cirrhosis. Curr Hepatology Rep 17, 8–14 (2018). https://doi.org/10.1007/s11901-018-0384-z
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11901-018-0384-z